{
    "2020-07-16": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Danaher Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release",
                "features": {
                    "keywords": [
                        "Danaher",
                        "earnings estimates",
                        "Q2 release"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Danaher Corporation's Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?",
                "features": {
                    "keywords": [
                        "Danaher Corporation",
                        "stock rallying",
                        "financials ambiguous",
                        "momentum"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "industrial"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "ambiguous"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs",
                "features": {
                    "keywords": [
                        "Rapid Molecular Test",
                        "Tuberculosis",
                        "Resistance Detection",
                        "First-Line Drugs",
                        "Second-Line Drugs"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}